CC
| |
Checkpoint Capital L.P.13F | |
Checkpoint Capital L.P. | |
Last update 2024-08-14 | 16 Stocks (4 new) |
Value $166.00 Mil | Turnover 23 % |
Portfolio Report |
Checkpoint Capital L.P. Top Holdings of 2024-06-30
View Full List
Ticker | | Company | Shares | Value ($1000) | Shares Change % | Weighting % | Trade Impact % | % of Shares outstanding | 3M Change % | YTD Change % | Market Cap $Mil | Industry |
---|---|---|---|---|---|---|---|---|---|---|---|---|
RYTM | Rhythm Pharmaceuticals Inc | 922,100 | 37861.430 | +11.70% | 22.820 | +2.39% | 1.510 | +46.56% | +38.87% | 3927.107 | Biotechnology | |
ARGX | argenx SE | 82,150 | 35327.790 | +0.18% | 21.300 | +0.04% | 0.140 | +18.93% | +55.43% | 36342.008 | Biotechnology | |
AXSM | Axsome Therapeutics Inc | 290,772 | 23407.150 | +119.55% | 14.110 | +7.68% | 0.610 | +8.17% | +13.96% | 4353.619 | Biotechnology | |
AVDL | Avadel Pharmaceuticals PLC | 1,138,178 | 16002.780 | +62.28% | 9.650 | +3.70% | 1.180 | -2.36% | +11.33% | 1513.375 | Drug Manufacturers | |
PTGX | Protagonist Therapeutics Inc | 355,000 | 12300.750 | +26.65% | 7.420 | +1.56% | 0.600 | +33.08% | +107.72% | 2804.446 | Biotechnology | |
CYTK | Cytokinetics Inc | 190,000 | 10294.200 | 0% | 6.210 | 0% | 0.160 | +9.02% | -33.12% | 6570.112 | Biotechnology | |
PHAT | Phathom Pharmaceuticals Inc | 875,000 | 9012.500 | +96.56% | 5.430 | +2.67% | 1.470 | +71.14% | +102.63% | 1263.357 | Biotechnology | |
CORT | Corcept Therapeutics Inc | 244,750 | 7951.930 | -10.60% | 4.790 | -0.49% | 0.230 | +59.47% | +67.18% | 5689.292 | Biotechnology | |
ATYR | aTyr Pharma Inc | 1,946,477 | 3036.500 | +34.57% | 1.830 | +0.47% | 2.820 | +74.16% | +119.86% | 234.968 | Biotechnology | |
PLRX | Pliant Therapeutics Inc | 232,200 | 2496.150 | New Holding | 1.500 | +1.50% | 0.380 | +21.13% | -16.12% | 923.575 | Biotechnology |
Checkpoint Capital L.P.'s Historical Top Holdings Breakdowns
Checkpoint Capital L.P.'s Top Stock Picks
View Full List
Ticker | | Company | Date | Action | Impact % | Price Range | Price | Price Change from Avrg% | Comment | Current Shares | Share Change |
---|---|---|---|---|---|---|---|---|---|---|---|
AXSM | Axsome Therapeutics Inc | 2024-06-30 | Add | +7.68% | 65.72 ($74.04) 80.5 | $90.70 | 22.50% | Add 119.55% | 290,772 | 158,335 | |
MIRM | Mirum Pharmaceuticals Inc | 2024-06-30 | Sold Out | -6.08% | 23.57 ($26.22) 34.85 | $41.08 | 56.67% | Sold Out | 0 | -362,193 | |
AVDL | Avadel Pharmaceuticals PLC | 2024-06-30 | Add | +3.70% | 14.06 ($16.3) 18.82 | $15.72 | -3.56% | Add 62.28% | 1,138,178 | 436,791 | |
IRWD | Ironwood Pharmaceuticals Inc | 2024-06-30 | Sold Out | -3.60% | 5.58 ($7.07) 8.61 | $4.66 | -34.09% | Sold Out | 0 | -618,528 | |
PHAT | Phathom Pharmaceuticals Inc | 2024-06-30 | Add | +2.67% | 8.97 ($10.3) 12.05 | $18.50 | 79.61% | Add 96.56% | 875,000 | 429,839 | |
RYTM | Rhythm Pharmaceuticals Inc | 2024-06-30 | Add | +2.39% | 35.41 ($39.92) 44.37 | $63.90 | 60.07% | Add 11.7% | 922,100 | 96,600 | |
PTGX | Protagonist Therapeutics Inc | 2024-06-30 | Add | +1.56% | 24.66 ($29.29) 34.8 | $47.61 | 62.55% | Add 26.65% | 355,000 | 74,699 | |
PLRX | Pliant Therapeutics Inc | 2024-06-30 | New Buy | +1.50% | 10.58 ($12.89) 15.61 | $15.19 | 17.84% | New holding | 232,200 | 232,200 | |
KYMR | Kymera Therapeutics Inc | 2024-06-30 | New Buy | +1.48% | 29.85 ($34.62) 39.42 | $49.86 | 44.02% | New holding | 82,000 | 82,000 | |
VSTM | Verastem Inc | 2024-06-30 | Sold Out | -1.33% | 2.9 ($8.24) 13.16 | $3.60 | -56.31% | Sold Out | 0 | -168,739 |
Checkpoint Capital L.P. Total Holding History ($B)
Checkpoint Capital L.P.'s Asset Allocation
Checkpoint Capital L.P. Past Portfolios
Portfolio Date | Number of Stocks | New Stocks | Total Value ($Mil) | Q/Q Turnover |
---|---|---|---|---|
Top Ranked Articles
- 1
Checkpoint Capital L.P.'s Hypothetical Growth since 2024-06-30
Checkpoint Capital L.P.'s Yearly Returns
Year | Portfolio % | % | Excess Gain % |
---|
Checkpoint Capital L.P.'s Holdings Heat Map
Size field:
Checkpoint Capital L.P.'s Holdings Bubble Chart
Checkpoint Capital L.P. News
- 1